Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PROCTER & GAMBLE HEALTH vs GLENMARK PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PROCTER & GAMBLE HEALTH GLENMARK PHARMA PROCTER & GAMBLE HEALTH/
GLENMARK PHARMA
 
P/E (TTM) x 34.6 -31.5 - View Chart
P/BV x 10.6 2.9 368.8% View Chart
Dividend Yield % 2.0 0.3 771.4%  

Financials

 PROCTER & GAMBLE HEALTH   GLENMARK PHARMA
EQUITY SHARE DATA
    PROCTER & GAMBLE HEALTH
Jun-23
GLENMARK PHARMA
Mar-23
PROCTER & GAMBLE HEALTH/
GLENMARK PHARMA
5-Yr Chart
Click to enlarge
High Rs5,366487 1,101.4%   
Low Rs3,883349 1,112.9%   
Sales per share (Unadj.) Rs740.7460.4 160.9%  
Earnings per share (Unadj.) Rs138.213.4 1,033.5%  
Cash flow per share (Unadj.) Rs155.235.0 442.8%  
Dividends per share (Unadj.) Rs95.002.50 3,800.0%  
Avg Dividend yield %2.10.6 343.5%  
Book value per share (Unadj.) Rs447.6335.1 133.6%  
Shares outstanding (eoy) m16.60282.17 5.9%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x6.20.9 687.5%   
Avg P/E ratio x33.531.3 107.0%  
P/CF ratio (eoy) x29.811.9 249.8%  
Price / Book Value ratio x10.31.2 828.2%  
Dividend payout %68.718.7 367.7%   
Avg Mkt Cap Rs m76,761117,953 65.1%   
No. of employees `000NANA-   
Total wages/salary Rs m2,06227,810 7.4%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m12,296129,901 9.5%  
Other income Rs m1843,168 5.8%   
Total revenues Rs m12,480133,069 9.4%   
Gross profit Rs m3,24715,125 21.5%  
Depreciation Rs m2816,113 4.6%   
Interest Rs m83,496 0.2%   
Profit before tax Rs m3,1428,685 36.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m8474,911 17.3%   
Profit after tax Rs m2,2953,774 60.8%  
Gross profit margin %26.411.6 226.8%  
Effective tax rate %27.056.5 47.7%   
Net profit margin %18.72.9 642.3%  
BALANCE SHEET DATA
Current assets Rs m11,71398,737 11.9%   
Current liabilities Rs m6,79150,455 13.5%   
Net working cap to sales %40.037.2 107.7%  
Current ratio x1.72.0 88.1%  
Inventory Days Days2637 3,922.7%  
Debtors Days Days343115 298.2%  
Net fixed assets Rs m10,61776,920 13.8%   
Share capital Rs m166282 58.8%   
"Free" reserves Rs m7,26594,281 7.7%   
Net worth Rs m7,43194,563 7.9%   
Long term debt Rs m038,521 0.0%   
Total assets Rs m22,330175,658 12.7%  
Interest coverage x409.13.5 11,740.0%   
Debt to equity ratio x00.4 0.0%  
Sales to assets ratio x0.60.7 74.5%   
Return on assets %10.34.1 249.1%  
Return on equity %30.94.0 773.8%  
Return on capital %42.49.2 463.1%  
Exports to sales %00-   
Imports to sales %13.10-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs m1,605NA-   
Fx inflow Rs m1,46546,464 3.2%   
Fx outflow Rs m1,60512,712 12.6%   
Net fx Rs m-14033,751 -0.4%   
CASH FLOW
From Operations Rs m2,3606,254 37.7%  
From Investments Rs m-215-5,285 4.1%  
From Financial Activity Rs m-985-775 127.1%  
Net Cashflow Rs m1,160325 357.0%  

Share Holding

Indian Promoters % 0.0 46.7 -  
Foreign collaborators % 51.8 0.0 -  
Indian inst/Mut Fund % 20.3 34.7 58.4%  
FIIs % 7.6 23.7 32.1%  
ADR/GDR % 0.0 0.0 -  
Free float % 48.2 53.4 90.3%  
Shareholders   56,730 209,931 27.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PROCTER & GAMBLE HEALTH With:   SUN PHARMA    DIVIS LABORATORIES    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on Procter & Gamble Health vs Glenmark Pharma

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Procter & Gamble Health vs Glenmark Pharma Share Price Performance

Period Procter & Gamble Health Glenmark Pharma S&P BSE HEALTHCARE
1-Day -0.20% -0.44% 1.17%
1-Month -7.15% 5.30% -0.76%
1-Year -2.68% 113.23% 61.81%
3-Year CAGR -9.02% 27.56% 18.16%
5-Year CAGR 5.83% 8.08% 19.78%

* Compound Annual Growth Rate

Here are more details on the Procter & Gamble Health share price and the Glenmark Pharma share price.

Moving on to shareholding structures...

The promoters of Procter & Gamble Health hold a 51.8% stake in the company. In case of Glenmark Pharma the stake stands at 46.7%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Procter & Gamble Health and the shareholding pattern of Glenmark Pharma.

Finally, a word on dividends...

In the most recent financial year, Procter & Gamble Health paid a dividend of Rs 95.0 per share. This amounted to a Dividend Payout ratio of 68.7%.

Glenmark Pharma paid Rs 2.5, and its dividend payout ratio stood at 18.7%.

You may visit here to review the dividend history of Procter & Gamble Health, and the dividend history of Glenmark Pharma.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 550 Points| Nifty Tops 22,250 | Power Stocks Shine Sensex Today Rallies 550 Points| Nifty Tops 22,250 | Power Stocks Shine(10:30 am)

Asian markets traded lower, while the US stock indices ended higher overnight with the S&P 500 hitting a record closing high ahead of key economic data.